Prognostic factors for survival after complete resections of synchronous lung cancers in multiple lobes: Pooled analysis based on individual patient data

Annals of Oncology

Volumn 24, Issue 4, 2013, Pages 889-894

  Tanvetyanon, T ^a   Finley, D J ^b   Fabian, T ^c   Riquet, M ^d   Voltolini, L ^e   Kocaturk, C ^f   Fulp, W J ^a   Cerfolio, R J ^g   Park, B J ^h   Robinson, L A ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c ALBANY MEDICAL CENTER   (United States)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e UNIVERSITY HOSPITAL OF SIENA   (Italy)

^f Yedikule Hospital for Chest Disease and Thoracic Surgery   (Turkey)

^g University of Alabama at Birmingham   (United States)

^h Hackensack University Medical Center   (United States)

Author keywords

Lung cancer; Multiple; Prognosis; Surgery; Survival

Indexed keywords

AGE; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; GENDER; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TUMOR LOCALIZATION;

AGE FACTORS; AGED; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; PROGNOSIS; SEX FACTORS; TREATMENT OUTCOME;

EID: 84875627191     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds495     Document Type: Article

References (32)

1. Postmus PE, Brambilla E, Chansky K Jr et al, The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer. J Thorac Oncol 2007; 2(8): 686-693.
2. Adebonojo SA, Moritz DM, Danby CA. The results of modern surgical therapy for multiple primary lung cancers. Chest 1997; 112(3): 693-701.
3. Ribet M, Dambron P. Multiple primary lung cancers. Eur J Cardiothorac Surg 1995; 9(5): 231-236.
4. Mathisen DJ, Jensik RJ, Faber LP et al. Survival following resection for second and third primary lung cancers. J Thorac Cardiovasc Surg 1984; 88(4): 502-510.
5. Ferguson MK, Demeester TR, Deslauriers J et al. Diagnosis and management of synchronous lung cancers. J Thorac Cardiovasc Surg 1985; 89(3): 378-385.
6. Van Bodegom PC, Wagenaar SS, Corrin B et al. Second primary lung cancer: importance of long term follow up. Thorax 1989; 44(10): 788-793.
7. William WN, Jr, Lin HY, Lee JJ et al. Revisiting stage IIIB and IV non-small cell lung cancer: analysis of the surveillance, epidemiology, and end results data. Chest 2009; 136(3): 701-709.
8. Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg 1975; 70(4): 606-612.
9. Antakli T, Schaefer RF, Rutherford JE et al. Second primary lung cancer. Ann Thorac Surg 1995; 59(4): 863-866.
10. Detterbeck FC, Jones DR, Funkhouser WK. Satellite nodules and multiple primary cancers. In Detterbeck FC, Socinski MA, Rosenman JG, Rivera MP (eds), Diagnosis and Treatment of Lung Cancer. Philadelphia, PA: Saunders 2001; 437-449.
11. Finley DJ, Yoshizawa A, Travis W et al. Predictors of outcomes after surgical treatment of synchronous primary lung cancers. J Thorac Oncol 2010; 5(2): 197-205.
12. Trousse D, Barlesi F, Loundou A et al. Synchronous multiple primary lung cancer: an increasing clinical occurrence requiring multidisciplinary management. J Thorac Cardiovasc Surg 2007; 133(5): 1193-1200.
13. De Leyn P, Moons J, Vansteenkiste J et al, Survival after resection of synchronous bilateral lung cancer. Eur J Cardiothorac Surg 2008; 34(6): 1215-1222.
14. Von Elm, Altman DG, Egger M et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Ann Intern Med 2007; 147: 573-577.
15. Moher D, Liberati A, Tetzlaff J et al. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009; 151(4): 264-269, W64.
16. Gordon I, Boffetta P, Demers PA. A case study comparing a meta-analysis and a pooled analysis of studies of sinonasal cancer among wood workers. Epidemiology 1998; 9(5): 518-524.
17. Tierney JF, Stewart LA, Ghersi D et al. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007; 8: 16.
18. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21(11): 1539-1558.
19. Friedenreich CM. Methods for pooled analyses of epidemiologic studies. Epidemiology 1993; 4(4): 295-302.
20. Sanderson S, Tatt ID, Higgins JP. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int J Epidemiol 2007; 36(3): 666-676.
21. Tanvetyanon T, Robinson L, Sommers KE et al. Relationship between tumor size and survival among patients with resection of multiple synchronous lung cancers. J Thorac Oncol 2010; 5(7): 1018-1024.
22. Voltolini L, Rapicetta C, Luzzi L et al. Surgical treatment of synchronous multiple lung cancer located in a different lobe or lung: high survival in node-negative subgroup. Eur J Cardiothorac Surg 2010; 37(5): 1198-1204.
23. Fabian T, Bryant AS, Mouhlas AL et al. Survival after resection of synchronous non-small cell lung cancer. J Thorac Cardiovasc Surg 2011; 142(3): 547-553.
24. Kocaturk CI, Gunluoglu MZ, Cansever L et al. Survival and prognostic factors in surgically resected synchronous multiple primary lung cancers. Eur J Cardiothorac Surg 2011; 39(2): 160-166.
25. Riquet M, Cazes A, Pfeuty K et al. Multiple lung cancers prognosis: what about histology? Ann Thorac Surg 2008; 86(3): 921-926.
26. Roberts JR, Schumaker D. An algorithm for managing bilateral lung masses. J Clin Oncol 2004; 22(14S): abstract 7371.
27. Rostad H, Strand TE, Naalsund A et al. Resected synchronous primary malignant lung tumors: a population-based study. Ann Thorac Surg 2008; 85(1): 204-209.
28. Jung EJ, Lee JH, Jeon K et al. Treatment outcomes for patients with synchronous multiple primary non-small cell lung cancer. Lung Cancer 2011; 73(2): 237-242.
29. Travis WD, Brambilla E, Noguchi M et al. Multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011; 6(2): 244-285.
30. Barsky SH, Cameron R, Osann KE et al. Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features. Cancer 1994; 73(4): 1163.
31. Vazquez M, Carter D, Brambilla E et al. Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: histopathologic features and their prognostic implications. Lung Cancer 2009; 64(2): 148-154.
32. Miller VA, Riely GJ, Zakowski MF et al. Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib. J Clin Oncol 2008; 26(9): 1472-1478.